Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Enveric’s EB-003 selected as lead candidate for mental health disorders [Pharmaceutical Technology]
December 29, 2023
Trip Or No Trip Pharmas Are Taking Psychedelic Trials To Australia [Clinical Leader]
December 13, 2023
The Path to Regulation of Psychedelic Therapies with Dr. Joe Tucker Enveric Biosciences [Digital Politics with Karen Jagoda]
December 6, 2023
Joseph Tucker – Drugs for Neuroplasticity [The Mindfulness Experience Podcast]
November 4, 2023
Psilocin prodrug receives USPTO development approval [Psychedelic Health]
November 2, 2023
Aligning financial plans to long-term goals [The CFO]
October 19, 2023
Has British biotech outgrown the Square Mile? [Proactive]
October 5, 2023
Biotech firm receives patent for psilocybin-derived mental health therapeutics [Helio]
October 2, 2023
Psilocybin-Based Drug Candidate Gains Patent [High Times]
October 2, 2023
U.S. approval for psychedelic drug MDMA nears after success in clinic [Labiotech]
September 22, 2023
‹
1
…
4
5
6
7
8
…
12
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
